chlorzoxazone has been researched along with Autoimmune Diabetes in 2 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Hall, SD | 1 |
| Maya, JF | 1 |
| Li, L | 1 |
| Asghar, A | 1 |
| Gorski, JC | 1 |
| Lucas, D | 1 |
| Farez, C | 1 |
| Bardou, LG | 1 |
| Vaisse, J | 1 |
| Attali, JR | 1 |
| Valensi, P | 1 |
2 other studies available for chlorzoxazone and Autoimmune Diabetes
| Article | Year |
|---|---|
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Topics: Adolescent; Adult; Aged; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diabetes Mellitus, Type 1; Diabetes | 2003 |
Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation.
Topics: Adult; Analysis of Variance; Chlorzoxazone; Cytochrome P-450 CYP2E1; Diabetes Mellitus; Diabetes Mel | 1998 |